Golden data on October 4th, according to the data disclosed by the Hong Kong Stock Exchange today (October 4th), Xinda Biotechnology (01801.HK) founder, executive director, board chairman and CEO Yu Dechao collectively sold 3.25 million shares on September 30th and October 2nd, totaling approximately 152 million Hong Kong dollars. After the sale, Yu Dechao’s shareholding ratio decreased from 7.90% to 7.70%, with the number of shares held decreasing to approximately 125.97 million shares.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Innovent Biologics: Kurucu Yu Dechao, hisselerinde yaklaşık 152 milyon HK $ azalttı
Golden data on October 4th, according to the data disclosed by the Hong Kong Stock Exchange today (October 4th), Xinda Biotechnology (01801.HK) founder, executive director, board chairman and CEO Yu Dechao collectively sold 3.25 million shares on September 30th and October 2nd, totaling approximately 152 million Hong Kong dollars. After the sale, Yu Dechao’s shareholding ratio decreased from 7.90% to 7.70%, with the number of shares held decreasing to approximately 125.97 million shares.